Method and biomarkers for the detection of dengue hemorrhagic fever
US10168337B2 · kind B2 · utility
2Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 2012 |
| Grant date | Jan 1, 2019 |
| Priority date | — |
| Expiry date | Apr 6, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides compositions and methods for detecting, analyzing, and identifying biomolecules used to diagnose patient with risk of DHF. More particularly, the invention provides plasma biomarkers including complement factor D to complement factor H (FactorD/FactorH) ratio and levels of one or more of IL2, desmoplakin, and high molecular weight albumin, which are used to detect risk of developing DHF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.